White Papers

  1. Managing The Challenges Of Controlled Room Temperature Requirements

    Controlled room temperature (CRT) cold chain packaging has many uses, but this versatile product also has challenges that are unique due to its requirement that the payload be kept between 15-25° Celsius. That’s neither very hot nor very cold, so fluctuations in the ambient temperature above and below can occur often during the shipping duration. This will stress a CRT shipper, unless it’s designed to deal with both warm and cool temperatures during its journey.

  2. 2017 Serialization & Traceability Trends

    Pharmaceutical companies have been working diligently to meet global product traceability mandates, particularly the November 2017 U.S. Drug Supply Chain Security Act (DSCSA) serialization requirements.  KPMG’s 2017 Serialization & Traceability Trends Survey found that 45% of respondents have investment more than $50 million to build the necessary capabilities for compliance.

  3. Measuring With Vision Inspection In Plastic Bottle Manufacturing

    To avoid costly production losses, container manufacturers are turning to Vision Inspection Systems to identify container defects. A properly calibrated Vision Inspection System can spot container defects before filling, preventing contamination and spillage, reducing waste and improving standards compliance.

  4. Solutions To Global Pharmaceutical Supply Chain Challenges

    Find out how a contract packaging company can deliver the expertise and flexibility needed to ship pharmaceuticals internationally.

  5. Outsourcing Strategies: Selecting The Right Contract Packaging Organization

    The pharmaceutical supply chain has been in a state of evolution ever since it began. At varying points along the timeline, mini revolutions occurred. Around the turn of the century, apothecaries and the makers of dyes and textiles merged sciences and efforts to take advantage of unique discoveries on both sides. Companies such as Bayer, Schering, Sandoz, Abbott, Pfizer, Smith Kline, Eli Lilly, Squibb, and Upjohn emerged as apothecaries and drug suppliers between the early 1830s and late 1890s. Their production had a profound effect on human health. In 1900, one third of all deaths were from pneumonia, diarrhea, and tuberculosis. Today, only pneumonia remains on the top ten killer list (mainly as a side effect of cardiovascular disease and cancer).

  6. The Emergence Of Foil Packaging In Pharma

    Foil packaging, plain and simple, is the most effective means of immediate shelf differentiation and lift in sales.  A high-end looking foil package conveys several things to the consumer: New, Better, Advanced Formula, Superior Product, High Quality, Classy.  It also suggests that the other products on the shelf are inferior in some way, of a lesser quality, value or class.  “Bling” remains King… When given the choice between two products that otherwise seem the same, consumers overwhelmingly chose the better looking and more visible package.

  7. Key Considerations When Selecting A Pharmaceutical Contract Packaging Service Provider

    Choosing the right packager for your products can be a daunting task and one that should not be taken lightly. There are numerous companies that claim to be expert packagers. However, when entrusting an outsource party to serve your supply chain, it is imperative to choose a partner that has a similar culture and shares a similar vision. Additionally, one that employs values and integrity instilling these traits within their associates is invaluable. The following eight elements are a guide to selecting a qualified outsource partner.

  8. Forecasting Accurately With Your Pharmaceutical Contract Packaging Organization

    Let’s face it, not all pharmaceutical drug launches are blockbusters. Even after carefully modeling the market to forecast potential sales, the underlying data used may prove to have some challenges. Many sales forecasts are based on the idea that the market can be represented as a continuous variable, but this may not be the case for a generic product whose fate may be determined by a single decision on the part of a drug wholesale company.

  9. Blow-Fill-Seal For Biologics: Breaking Through The Glass Ceiling Of Pharmaceutical Packaging

    As the industry continues its move toward biologics, innovative solutions and technologies will be needed to ensure a safe and reliable approach to the manufacturing and delivery of these drugs. One option is to leverage the advanced aseptic manufacturing of blow-fill-seal (B/F/S) technology, which has the potential to address the challenges of traditional glass filling as well as the global distribution of biologics.

  10. The Impact Of Patient Compliance On Pharma Manufacturers

    Research shows that half of all patients in the United States and the European Union do not take their medicines as prescribed. Poor patient compliance, or medication adherence can lead to worsening of disease, serious and avoidable health risks, increased hospitalization, and even death. In fact, patient non-compliance is the fourth leading cause of death in the United States, and the annual cost of non-compliance in the U.S. is estimated to be $317 billion and $125 billion in the EU, according to research group MarketWatch.